Business
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research
The program will integrate the Company’s clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubesTYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing on the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a new development and
About this update from Envue Medical, Inc.
[{"type":"image","alt":"ENvue Medical, Inc.","displaySize":"","headline":null,"caption":"ENvue Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":79,"url":"https://media.zenfs.com/en/globenewswire.com/e735564e4b61ea457ed5c24973dfd284"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jnXolgcAdzqINbRTdJetTg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e735564e4b61ea457ed5c24973dfd284","width":300,"height":79}},"lazy":false},{"type":"text","content":"The program will integrate the Company’s clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubes","length":149,"tagName":"p"},{"type":"text","content":"TYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing on the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a new development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric (NG) tubes.","length":522,"tagName":"p"},{"type":"text","content":"Nasogastric tubes are among the most widely used devices in hospital care and are frequently required to remain in place for extended periods. While clinically essential, indwelling NG tubes are commonly associated with nasal and throat discomfort during the dwell phase, an issue for which limited mitigation options currently exist.¹,²,³","length":339,"tagName":"p"},{"type":"text","content":"The newly launched program builds on previously published, peer-reviewed clinical research (link to full publication) demonstrating that surface acoustic wave micro-vibration technology applied to nasogastric tubes can reduce friction at the tube–tissue interface during indwelling use.4","length":287,"tagName":"p"},{"type":"text","content":"Doron Besser, MD, CEO of ENvue Medical, commented, “We believe that this program represents a disciplined platform expansion initiative focused on improving the overall enteral care experience by addressing patient comfort during prolonged NG tube use. While this initiative is exploratory in nature and does not represen...